Your browser doesn't support javascript.
loading
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki.
Affiliation
  • Cho KY; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Nomoto H; Clinical Research and Medical Innovation Centre, Hokkaido University Hospital, Sapporo, Japan.
  • Nakamura A; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Kawata S; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Sugawara H; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Takeuchi J; Third Department of Internal Medicine, Hokkaido P.W.F.A.C Obihiro-Kosei General Hospital, Obihiro, Japan.
  • Nagai S; Sapporo Diabetes and Thyroid Clinic, Sapporo, Japan.
  • Tsuchida K; Division of Diabetes and Endocrinology, Department of Medicine, Sapporo Medical Centre, NTT East Corporation, Sapporo, Japan.
  • Omori K; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Yokoyama H; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Manda N; Department of Internal Medicine, Jiyugaoka Medical Clinic, Obihiro, Japan.
  • Kurihara Y; Department of Diabetes Centre, Manda Memorial Hospital, Sapporo, Japan.
  • Aoki S; Kurihara Clinic, Sapporo, Japan.
  • Atsumi T; Aoki Clinic, Sapporo, Japan.
  • Miyoshi H; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Diabetes Obes Metab ; 22(3): 458-462, 2020 03.
Article in En | MEDLINE | ID: mdl-31486230

Full text: 1 Database: MEDLINE Main subject: Symporters / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Symporters / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Year: 2020 Type: Article